Bleeding complications associated with dual antiplatelet therapy plus anticoagulant in patients who underwent percutaneous coronary intervention with drug-eluting stents

被引：0
|
作者：
Uchida, Yoshie [1 ]
Tsurumi, Yukio [1 ]
Takahashi, Atsushi [1 ]
Higasitani, Michiaki [1 ]
Kameyama, Kinichi [1 ]
Nagashima, Michitaka [1 ]
Mori, Furmaki [1 ]
Takagi, Atsushi [1 ]
Shiga, Tsuyoshi [1 ]
Hagiwara, Nobuhisa [1 ]
Kasanuki, Hiroshi [1 ]
机构：
[1] Tokyo Womens Med Univ, Tokyo, Japan
来源：
CIRCULATION | 2007年 / 116卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3474
引用
收藏
页码：786 / 786
页数：1
相关论文
共 50 条
  • [41] The optimal duration of dual antiplatelet therapy in East Asian patients undergoing percutaneous coronary intervention with drug-eluting stents: a meta-analysis of randomized trials
    Sun, Yuchao
    Liu, Xiaohua
    Xu, Yizhou
    CORONARY ARTERY DISEASE, 2021, 32 (02) : 119 - 130
  • [42] Safety and efficacy of prolonged dual antiplatelet therapy following complex percutaneous coronary artery revascularization with drug-eluting stents
    Giustino, G.
    Chieffo, A.
    Palmerini, T.
    Valgimigli, M.
    Feres, F.
    Abizaid, A.
    Hong, M. K.
    Kim, H. S.
    Gilard, M.
    Morice, M. C.
    Leon, M. B.
    Bhatt, D. L.
    Genereux, P.
    Stone, G. W.
    Colombo, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 839 - 839
  • [43] Safety of short-term dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting balloons
    Bonaventura, K.
    Sonntag, S.
    Fengler, A.
    Roettgen, A.
    Kleber, F. X.
    EUROPEAN HEART JOURNAL, 2011, 32 : 244 - 244
  • [44] Safety of Dual Antiplatelet Therapy in Patients Treated with Coronary Drug Eluting Stents
    Drewnicki, Andrzej
    Lesiak, Maciej
    Pyda, Malgorzata
    Grygier, Marek
    Skorupski, Wlodzimierz
    Araszkiewicz, Aleksander
    Mitkowski, Przemyslaw
    Grajek, Stefan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B41 - B41
  • [45] The impact of diabetes mellitus on in-hospital bleeding in patients undergoing percutaneous coronary intervention with drug-eluting stents
    Rha, S. W.
    Choi, B. G.
    Choi, S. Y.
    Byun, J. K.
    Choi, C. U.
    Kim, E. J.
    Park, C. G.
    Seo, H. S.
    Oh, D. J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 139 - 140
  • [46] Short Term Dual Antiplatelet Therapy After Percutaneous Coronary Intervention with Drug Eluting Stents: A Comprehensive Review of Literature
    Salehin, Salman
    Hasan, Syed Mustajab
    Hossain, Mohammad Dilwar
    Gilani, Syed
    Khalife, Wissam I.
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (08)
  • [47] Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents
    Zimarino, M
    Renda, G
    De Caterina, R
    DRUGS, 2005, 65 (06) : 725 - 732
  • [48] Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents REPLY
    Mauri, Laura
    Yeh, Robert W.
    Kereiakes, Dean J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (14): : 1373 - 1374
  • [49] Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents
    Marco Zimarino
    Giulia Renda
    Raffaele De Caterina
    Drugs, 2005, 65 : 725 - 732
  • [50] Perioperative management of antiplatelet therapy in patients with drug-eluting stents
    Dimitrova, G.
    Tulman, D. B.
    Bergese, S. D.
    HEART LUNG AND VESSELS, 2012, 4 (03) : 153 - 167
12345